Complexity and heterogeneity: what drives the ever-changing brain in Huntington's disease?
about
Gene therapy in mouse models of huntington disease.Basal Ganglia disorders associated with imbalances in the striatal striosome and matrix compartments.Stability of resting fMRI interregional correlations analyzed in subject-native space: a one-year longitudinal study in healthy adults and premanifest Huntington's diseaseAlterations in brain transition metals in Huntington disease: an evolving and intricate story.Comparison of vertical and horizontal saccade measures and their relation to gray matter changes in premanifest and manifest Huntington disease.Altered white matter microstructure in the corpus callosum in Huntington's disease: implications for cortical "disconnection".Metabolic network as a progression biomarker of premanifest Huntington's disease.Of mice, rats and men: Revisiting the quinolinic acid hypothesis of Huntington's disease.Molecular mechanisms and potential therapeutical targets in Huntington's disease.Protein modifications involved in neurotransmitter and gasotransmitter signaling.Brain networks in Huntington disease.Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function.Challenges of Huntington's disease and quest for therapeutic biomarkers.The Complexity of Clinical Huntington's Disease: Developments in Molecular Genetics, Neuropathology and Neuroimaging Biomarkers.Longitudinal analysis of the electroencephalogram and sleep phenotype in the R6/2 mouse model of Huntington's disease.Moving toward a gene therapy for Huntington's disease.Ifngr1 and Stat1 mediated canonical Ifn-γ signaling drives nigrostriatal degeneration.
P2860
Q35090208-DC1DD7BB-20CC-4662-9798-30D55C16255FQ35208420-EF2E8AB4-83B4-4500-97BD-6589C33255D9Q35663246-BCD1D5DE-CD17-42BD-AB29-0EF92C5554DBQ36838442-72F726B6-367C-4318-B740-A6B0B93773CCQ36988659-1DA0F95A-96B1-43CF-A733-30AA45316383Q37052324-8EE4E8F3-6811-4910-8EF1-2A83079408C5Q37123932-CC01AEA0-4095-400C-9531-4006D20F6599Q37460122-CF2F0ACD-F996-4694-BC36-B1967492DBD8Q37776087-06F2D5D6-5F8E-4F02-A977-4304A2AB5B75Q37789075-8B9FECB7-C457-4601-B944-9D5D7438F88CQ37834193-C49833C9-93DD-4681-88D4-0D069A7E420BQ37930190-29F4948C-12B7-4AB2-ACC9-28B4E65527D2Q38257697-431FDB5C-5EE4-49EC-AA77-723309635A3EQ38663086-760B233E-2CC6-4547-B993-7CECC01117D4Q44250471-0FE19A1A-A415-4FA4-9F14-587E1445D1B4Q45291688-1C7ADB87-2FE1-4CB1-B236-6DB7B36109E0Q47382007-D64C2076-3E56-4EAD-A9C7-3FA8609B6C76
P2860
Complexity and heterogeneity: what drives the ever-changing brain in Huntington's disease?
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Complexity and heterogeneity: ...... brain in Huntington's disease?
@ast
Complexity and heterogeneity: ...... brain in Huntington's disease?
@en
type
label
Complexity and heterogeneity: ...... brain in Huntington's disease?
@ast
Complexity and heterogeneity: ...... brain in Huntington's disease?
@en
prefLabel
Complexity and heterogeneity: ...... brain in Huntington's disease?
@ast
Complexity and heterogeneity: ...... brain in Huntington's disease?
@en
P2093
P2860
P356
P1476
Complexity and heterogeneity: ...... brain in Huntington's disease?
@en
P2093
Alexandra K Zaleta
David H Salat
H Diana Rosas
Nathanael Hevelone
Stephanie Y Lee
P2860
P304
P356
10.1196/ANNALS.1427.034
P407
P577
2008-12-01T00:00:00Z